Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium gluconate + magnesium chloride + sodium chloride + sodium acetate + potassium is a sterile isotonic multi-electrolyte intravenous solution represented by **Plasma-Lyte A** and **Plasma-Lyte 148** products. It provides water, sodium, potassium, magnesium, chloride, acetate, and gluconate to restore extracellular fluid volume and electrolyte balance. Acetate and gluconate are metabolizable anions that serve as bicarbonate precursors and provide an alkalinizing effect. It is used for hydration, treatment or prevention of electrolyte depletion, and correction of acid-base disturbances where an alkalinizing electrolyte solution is appropriate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium gluconate + magnesium chloride + sodium chloride + sodium acetate + potassium.